Medicine combination for repeat heart stent blockages
Treatments studied
Part of Heart & circulation, Pain clinical trials.
This trial tests combining two medicines (sirolimus and corticosteroids) to treat a specific type of heart stent blockage that keeps coming back. It aims to reduce the chance of the artery narrowing again after a recent procedure to open it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must have a rapid return of narrowing in your heart stent (a second or later recurrence)
- You must have had a successful heart procedure to reopen the artery within the past two weeks
- You must be on standard heart disease medications and have your treatment goals met
- You cannot be pregnant, allergic to the study drugs, or currently in another trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a balloon coated with a drug that may help keep arteries open after they've been cleared, especially for people with a narrowing inside a previously placed stent or in a small heart artery. It's a first-time-in-humans study to check if the treatment is safe and works.
This trial tests if anti-inflammatory drugs like prednisone or colchicine can prevent stents from blocking again in people who have already had multiple stent blockages. It may offer a new treatment option for those with recurrent in-stent restenosis.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This study tests a coronary stent approach for people with significantly blocked heart arteries. It may help by improving blood flow, and it compares treatment in a structured way while monitoring safety and outcomes.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
Hear when a new In-stent Restenosis Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.